Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Stay on the cutting edge of major market events in drug development. Powered by real-time intelligence, Biomedtracker’s web-based platform tracks and analyzes clinical and regulatory developments so you can quickly and accurately assess a drug's probability of technical success.
How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.
How it works
Biomedtracker’s intuitive interface features the latest, industry-acclaimed insights, all at your fingertips. We track impactful future catalysts, and then analyze these commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface that keeps you at the top of your game.
Our analysts attend the medical and investor meetings that matter to you, bringing you not just the news, but vital information on how it impacts your bottom line.
Real-time tracking and analysis of every event in drug development; customized email alerts
Monitor all aspects of the market from one place, from drugs, to targets, to trials, and more
Medical and investor conference planners and post-reports cover major meeting developments
Predict how FDA Panel Members might vote with AdComm Insight
Exclusive likelihood of approval analyses and access to our expert team.
Biomedtracker
By Amanda Micklus 19 Jun 2018
Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording, "RMAT Designation – Impact on Regenerative Medicine Sector".
Citeline, Scrip, Biomedtracker, Datamonitor Healthcare
By Mary Jo Laffler 29 May 2018
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.
Topic Clinical trials
Biomedtracker
10 May 2018
Get a reliable and accurate view of what’s on the horizon for pharma in the coming quarter. The Biomedtracker Q2 2018 Outlook Report includes essential information, including each drug’s likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group.
Topic Drug review
Biomedtracker
03 May 2018
What's on the horizon for pharma in 2018? Find out with Biomedtracker’s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.
Datamonitor Healthcare, Biomedtracker
05 Apr 2018
To beat your competition, turn to the combined power of Biomedtracker and Datamonitor Healthcare for the most reliable and timely information in the industry.
Topic Drug review
Biomedtracker
05 Apr 2018
For a look at the outcome of two catalysts featured in Biomedtracker’s Q4 2017 Outlook Report, download the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report.
Biomedtracker
05 Apr 2018
Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.
Topic Strategy
Biomedtracker
01 Nov 2017
Catalyst Roundup: A review of select catalysts from last quarter's outlook report
Topic Research
Biomedtracker
27 Oct 2017
In this report, we cover catalysts from 21 drugs expected to occur in Q4 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Topic Alzheimers Cancer Drug approval
Biomedtracker
10 Aug 2017
This free infographic comes to you from Biomedtracker, part of the Informa suite of Pharma Intelligence tools.
Topic Company analysis
Biomedtracker
17 Jul 2017
In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Topic Alzheimers Cancer Drug approval
Datamonitor Healthcare, Biomedtracker
14 Jun 2017
Featuring analysts from Informa’s Biomedtracker, Datamonitor Healthcare, and Citeline, the 2017 Informa Pharma Intelligence Post-ASCO Podcast provides commentary into ASCO 2017.
Biomedtracker
26 May 2017
The 53rd annual meeting of the American Society of Clinical Oncology (ASCO) will be held in Chicago from June 2-6, 2017. This audio-only podcast features Informa Pharma Intelligence analysts Dr. Robert Jeng (Biomedtracker), Dr. David Dahan (Biomedtracker), Dr. Dominique Fontanilla (Datamonitor Healthcare), and Dr. Maria Berezina (Citeline) as they discuss notable abstracts which were released on Wednesday, May 17, 2017.
Topic Cancer
Biomedtracker, Meddevicetracker
20 Apr 2017
High impact catalysts can lead to large changes in the valuation of drugs, devices, and companies, view the infographic to see the latest evaluation
Topic Drug review Research
Biomedtracker
03 Apr 2017
Learn why pharmaceutical, biotech, and investment companies rely on BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.
USA
Patricia specializes in
+27 year(s) experience
Gail specializes in
+22 year(s) experience
USA
Rachel specializes in
+22 year(s) experience
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
From discovery to patent expiry, and coverage spanning both ethical and generic drugs, Medtrack has you covered. Stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool.
Looking for more products Product Finder
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date